# Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/two-year-outcomes-of-clinical-n2-3-esophageal-squamous-cell-carcinoma-after/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yang Yang,Jun Liu,Zhichao Liu,Li Zhu,Hezhong Chen,Bentong Yu,Renquan Zhang,Jinchen Shao,Ming Zhang,Chun Guang Li,Zhigang Li |
| Citations | 53 |
| DOI | 10.1016/j.jtcvs.2023.08.056 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4386580126 |
| PMID | 37696429 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Jinchen Shao](https://scholariq.org/researchers/jinchen-shao/)

## Paper journal

- [Journal of Thoracic and Cardiovascular Surgery](https://scholariq.org/journals/journal-of-thoracic-and-cardiovascular-surgery/)

## Paper primary topic

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

## Paper topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.